Total Payments
$264,882
2021 Payments
$4,500
Companies
9
Transactions
480
Medicare Patients
959
Medicare Billing
$167,603
Payment Breakdown by Category
Other$205,276 (77.5%)
Travel$54,860 (20.7%)
Food & Beverage$4,297 (1.6%)
Consulting$442.50 (0.2%)
Education$6.09 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $205,276 | 106 | 77.5% |
| Travel and Lodging | $54,860 | 215 | 20.7% |
| Food and Beverage | $4,297 | 157 | 1.6% |
| Consulting Fee | $442.50 | 1 | 0.2% |
| Education | $6.09 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $202,022 | 359 | $0 (2021) |
| Allergan, Inc. | $28,528 | 61 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $17,196 | 35 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $13,614 | 15 | $0 (2018) |
| ITI, Inc. | $3,150 | 3 | $0 (2021) |
| Takeda Pharmaceuticals America, Inc. | $161.22 | 3 | $0 (2017) |
| Lundbeck LLC | $109.15 | 1 | $0 (2017) |
| Neurocrine Biosciences, Inc. | $87.44 | 2 | $0 (2020) |
| Alkermes, Inc. | $13.29 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $4,500 | 4 | Sunovion Pharmaceuticals Inc. ($3,150) |
| 2020 | $24,469 | 37 | Sunovion Pharmaceuticals Inc. ($18,432) |
| 2019 | $27,035 | 41 | Sunovion Pharmaceuticals Inc. ($22,674) |
| 2018 | $114,675 | 210 | Sunovion Pharmaceuticals Inc. ($84,303) |
| 2017 | $94,204 | 188 | Sunovion Pharmaceuticals Inc. ($73,462) |
All Payment Transactions
480 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/01/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,050.00 | General |
| Category: CNS | ||||||
| 06/16/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,050.00 | General |
| Category: CNS | ||||||
| 03/18/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,050.00 | General |
| Category: CNS | ||||||
| 02/18/2021 | ITI, Inc. | CAPLYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,350.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/15/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,050.00 | General |
| Category: CNS | ||||||
| 09/29/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: CNS | ||||||
| 09/15/2020 | ITI, Inc. | CAPLYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $900.00 | General |
| Category: PSYCHIATRY | ||||||
| 08/06/2020 | ITI, Inc. | CAPLYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $900.00 | General |
| Category: PSYCHIATRY | ||||||
| 03/18/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,015.00 | General |
| Category: CNS | ||||||
| 03/12/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,755.00 | General |
| Category: CNS | ||||||
| 03/12/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Travel and Lodging | In-kind items and services | $428.25 | General |
| Category: CNS | ||||||
| 03/12/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Travel and Lodging | In-kind items and services | $394.99 | General |
| Category: CNS | ||||||
| 03/12/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Travel and Lodging | In-kind items and services | $355.40 | General |
| Category: CNS | ||||||
| 03/12/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $118.42 | General |
| Category: CNS | ||||||
| 03/12/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | Cash or cash equivalent | $83.59 | General |
| Category: CNS | ||||||
| 03/12/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Travel and Lodging | Cash or cash equivalent | $34.50 | General |
| Category: CNS | ||||||
| 03/12/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Travel and Lodging | Cash or cash equivalent | $23.00 | General |
| Category: CNS | ||||||
| 03/12/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Travel and Lodging | Cash or cash equivalent | $18.00 | General |
| Category: CNS | ||||||
| 03/04/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,055.00 | General |
| Category: CNS | ||||||
| 03/04/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Travel and Lodging | Cash or cash equivalent | $123.05 | General |
| Category: CNS | ||||||
| 03/04/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | Cash or cash equivalent | $12.11 | General |
| Category: CNS | ||||||
| 02/28/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,030.00 | General |
| Category: CNS | ||||||
| 02/28/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Travel and Lodging | Cash or cash equivalent | $112.70 | General |
| Category: CNS | ||||||
| 02/28/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | Cash or cash equivalent | $17.97 | General |
| Category: CNS | ||||||
| 02/28/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $6.30 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 167 | 411 | $68,254 | $20,952 |
| 2022 | 6 | 269 | 863 | $134,916 | $52,687 |
| 2021 | 6 | 250 | 726 | $123,393 | $50,071 |
| 2020 | 6 | 273 | 640 | $148,506 | $43,893 |
Total Patients
959
Total Services
2,640
Medicare Billing
$167,603
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 39 | 75 | $25,202 | $7,234 | 28.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 53 | 99 | $22,747 | $6,724 | 29.6% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 33 | 168 | $6,613 | $3,714 | 56.2% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 31 | 56 | $13,216 | $3,132 | 23.7% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 11 | 13 | $476.00 | $147.20 | 30.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 71 | 230 | $49,158 | $19,081 | 38.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 63 | 132 | $43,758 | $14,694 | 33.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 45 | 115 | $27,140 | $10,003 | 36.9% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 52 | 333 | $12,631 | $7,885 | 62.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 17 | $1,281 | $517.90 | 40.4% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 26 | 36 | $948.00 | $505.95 | 53.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 78 | 235 | $45,992 | $19,058 | 41.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 58 | 174 | $41,064 | $15,131 | 36.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 48 | 87 | $27,864 | $10,293 | 36.9% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2021 | 36 | 165 | $6,132 | $4,205 | 68.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 17 | 20 | $1,480 | $834.74 | 56.4% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 13 | 45 | $861.00 | $549.06 | 63.8% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 68 | 187 | $44,132 | $15,569 | 35.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 86 | 175 | $58,884 | $13,842 | 23.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 75 | 216 | $41,744 | $12,622 | 30.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 16 | 16 | $1,888 | $852.36 | 45.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 15 | 18 | $1,286 | $628.43 | 48.9% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 13 | 28 | $572.00 | $379.73 | 66.4% |
About Dr. Annette Smick, MD
Dr. Annette Smick, MD is a Child & Adolescent Psychiatry healthcare provider based in Sioux Falls, South Dakota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982654877.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Annette Smick, MD has received a total of $264,882 in payments from pharmaceutical and medical device companies, with $4,500 received in 2021. These payments were reported across 480 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($205,276).
As a Medicare-enrolled provider, Smick has provided services to 959 Medicare beneficiaries, totaling 2,640 services with total Medicare billing of $167,603. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Child & Adolescent Psychiatry
- Other Specialties Psychiatry, Psychiatry
- Location Sioux Falls, SD
- Active Since 05/11/2006
- Last Updated 10/17/2025
- Taxonomy Code 2084P0804X
- Entity Type Individual
- NPI Number 1982654877
Products in Payments
- LATUDA (Drug) $202,022
- VRAYLAR (Drug) $28,528
- REXULTI (Drug) $17,196
- Trintellix (Drug) $13,775
- CAPLYTA (Drug) $3,150
- ABILIFY MAINTENA (Drug) $109.15
- INGREZZA (Drug) $87.44
- Aristada 441 mg (Drug) $13.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Child & Adolescent Psychiatry Doctors in Sioux Falls
Scott Schneider, M.d, M.D
Child & Adolescent Psychiatry — Payments: $24,606
Child & Adolescent Psychiatry $24,606
Timothy Soundy, M.d, M.D
Child & Adolescent Psychiatry — Payments: $632.59
Child & Adolescent Psychiatry $632.59
Matthew Eggers, Md, MD
Child & Adolescent Psychiatry — Payments: $274.00
Child & Adolescent Psychiatry $274.00
Dr. Nicole Christenson, M.d, M.D
Child & Adolescent Psychiatry — Payments: $195.12
Child & Adolescent Psychiatry $195.12
Adam Peterson, M.d, M.D
Child & Adolescent Psychiatry — Payments: $111.22
Child & Adolescent Psychiatry $111.22
Sarah Flynn, M.d, M.D
Child & Adolescent Psychiatry
Child & Adolescent Psychiatry